Literature DB >> 6480806

Specific insulin binding sites in human ovary.

L Poretsky, D Smith, M Seibel, A Pazianos, A C Moses, J S Flier.   

Abstract

The strong association between hyperinsulinemic states of insulin resistance and ovarian hyperandrogenism has led to the suggestion that insulin might directly influence the function of the ovary. To assess this possibility, we have attempted to directly measure insulin receptors in the ovarian stroma of three patients who were operated upon for polycystic ovarian disease. 125I-insulin binding was easily detectable in fragments of ovarian stroma in each case. Specific binding was totally inhibited by pre-treatment with serum containing specific anti-insulin receptor autoantibodies (B-2). These data are consistent with the hypothesis that insulin can directly influence ovarian function. Further studies of insulin receptors and insulin action in human ovarian tissue could lead to a better understanding of the link between insulin resistant states and ovarian hyperfunction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480806     DOI: 10.1210/jcem-59-4-809

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Hyperandrogenism, hyperinsulinism and polycystic ovarian disease.

Authors:  R Pasquali; S Venturoli
Journal:  J Endocrinol Invest       Date:  1986-12       Impact factor: 4.256

3.  Stimulatory effect of insulin on 5alpha-reductase type 1 (SRD5A1) expression through an Akt-dependent pathway in ovarian granulosa cells.

Authors:  Pradeep P Kayampilly; Brett L Wanamaker; James A Stewart; Carrie L Wagner; K M J Menon
Journal:  Endocrinology       Date:  2010-09-01       Impact factor: 4.736

4.  Insulin as a factor of increased androgen production in women with obesity and polycystic ovaries.

Authors:  R Pasquali; D Antenucci; F Casimirri; S Venturoli; R Paradisi; R Fabbri; N Melchionda; L Barbara
Journal:  J Endocrinol Invest       Date:  1987-12       Impact factor: 4.256

Review 5.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

6.  Insulin administration alters gonadal steroid metabolism independent of changes in gonadotropin secretion in insulin-resistant women with the polycystic ovary syndrome.

Authors:  A Dunaif; M Graf
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  Women with Type 1 diabetes (T1D) experience a shorter reproductive period compared with nondiabetic women: the Pittsburgh Epidemiology of Diabetes Complications (EDC) study and the Study of Women's Health Across the Nation (SWAN).

Authors:  Yan Yi; Samar R El Khoudary; Jeanine M Buchanich; Rachel G Miller; Debra Rubinstein; Karen Matthews; Trevor J Orchard; Tina Costacou
Journal:  Menopause       Date:  2021-03-01       Impact factor: 3.310

8.  The insulin signaling pathway is dysregulated in cumulus cells from obese, infertile women with polycystic ovarian syndrome with an absence of clinical insulin resistance.

Authors:  Mauricio B Chehin; Renato Fraietta; Aline R Lorenzon; Tatiana C S Bonetti; Eduardo L A Motta
Journal:  Ther Adv Reprod Health       Date:  2020-06-17

9.  Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects.

Authors:  Dorothea Kurzthaler; Dijana Hadziomerovic-Pekic; Ludwig Wildt; Beata E Seeber
Journal:  Reprod Biol Endocrinol       Date:  2014-10-11       Impact factor: 5.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.